Filter
389
Filtered Results: 389
Text search:
leishmaniosis
Featured
Recommendations
46
New Publications
87
Language
Document type
No document type
142
Studies & Reports
91
Guidelines
50
Strategic & Response Plan
25
Manuals
22
Resource Platforms
16
Videos
16
Fact sheets
11
Training Material
5
Infographics
5
Situation Updates
4
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
52
Latin America and the Carribbean
19
Ethiopia
14
Paraguay
13
India
12
Colombia
11
Syria
11
Nepal
9
Kenya
8
Bangladesh
8
Africa
7
Middle East and North Africa
5
Western and Central Europe
5
Uganda
5
Sudan
5
Venezuela
4
Jordan
4
Brazil
4
Ghana
3
Nigeria
3
Congo, Democratic Republic of
3
Bolivia
3
Lebanon
3
Zambia
3
South Sudan
3
Iraq
3
Somalia
3
Turkey
2
Iran
2
Malawi
2
Saudi Arabia
2
South–East Asia Region
2
East and Southern Africa
2
Eastern Europe
2
Pakistan
2
North Macedonia
1
Sierra Leone
1
Togo
1
China
1
Rwanda
1
Albania
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Cambodia
1
Asia
1
Tanzania
1
Germany
1
North America
1
Tunisia
1
South Africa
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Liberia
1
Ecuador
1
Myanmar / Burma
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
118
Clinical Guidelines
56
Public Health
35
Key Resources
20
Pharmacy & Technologies
5
Capacity Building
4
Women & Child Health
4
Toolboxes
NTDs
156
Planetary Health
23
HIV
14
Conflict
12
Rapid Response
11
COVID-19
8
Global Health Education
8
Refugee
7
Caregiver
5
TB
4
NCDs
4
Pharmacy
3
Natural Hazards
2
Zika
2
Mental Health
1
Disability
1
Cholera
1
Ebola & Marburg
1
Health Financing Toolbox
1
Polio
1
AMR
1
Leitlinie der Deutschen Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG) in Zusammenarbeit mit der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) und der Deutschen Dermatologischen Gesellschaft
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat).
Leishmaniasis is caused by protozoan parasites which are tra...
Indoor residual spraying (IRS) involves applying residual insecticide to potential vector resting sites on the interior surfaces of human dwellings or other buildings. The main aim of IRS is to kill vectors before they are able to transmit pathogens to humans. When carried out correctly, IRS has his...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
In 2007, the Sixtieth World Health Assembly adopted resolution WHA60.13 on control of leishmaniasis, urging Member States, among other actions: to strengthen prevention, active detection and treatment of cases of both cutaneous and visceral leishmaniasis in order to decrease the disease burden; and ...
Websites last accessed on 24.03.2023
Education and information about Leishmaniasis prevention and control.
Website last accessed on 14.04.2023
Health workers Luke (Kenya), Juliana (Colombia), and Shishu (India) share the same hope for their patients with leishmaniasis: simple, oral treatments. For the first time ever, it seems leishmaniasis research is moving from neglect to a sense of hope.
MEDBOX Issue Brief no.35: The first issue brief on the NTD Toolbox contains general strategies, roadmaps, key treatment guidelines, reports, and training material on Buruli ulcer, Chagas, and Leishmaniasis.
Website last accessed on 18.03.2023
WHO often receives requests from Member States and implementing partners to provide training in capacity‐building in endemic areas in order to better equip health personnel to diagnose, treat and control the disease.
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
